EUVIMEDEUVIMED entdecken
Open Access

Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ

Shu Yang iD, Lijiao Xiong, Tingfeng Liao, Lixing Li, Yanchun Li, Lin Kang, Guangyan Yang, Zhen Liang iD

Diabetes · 2025

DOI: 10.2337/db24-0375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, 2025. Verfasst von Shu Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, Guangd…. Hauptthemen laut MEDLINE: PPAR gamma, Muscular Atrophy, Muscle, Skeletal, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Shenzhen Sustainable Development Science and Technology Special Project, China, Key Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance, a hallmark of type 2 diabetes, accelerates muscle breakdown and impairs energy metabolism. However, the role of Ubiquitin Specific Peptidase 2 (USP2), a key regulator of insulin resistance, in sarcopenia remains unclear. Peroxisome proliferator activated receptor γ (PPARγ) plays a critical role in regulating muscle atrophy. This study investigates the role of deubiquitinase USP2 in mitigating muscle atrophy. Our findings revealed reduced USP2 expression in skeletal muscles of patients with type 2 diabetes. In mouse models of diabetes- and dexamethasone (DEX)-induced muscle atrophy, USP2 expression was downregulated in skeletal muscles. Usp2 knockout exacerbated muscle loss and functional impairment induced by diabetes or DEX. Moreover, skeletal muscle-specific Usp2 knockout further aggravated muscle loss and functional impairment induced by diabetes. Local injection of AAV-Usp2 into the gastrocnemius muscles of diabetic mice increased muscle mass, and improved skeletal muscle performance and endurance. It enhanced insulin sensitivity in diabetic mice, shown by lower fasting serum glucose and insulin levels and better glucose tolerance. Mechanistic analysis showed USP2 directly interacted with PPARγ by deubiquitinating it, stabilizing its protein levels, enhancing insulin signaling and sensitivity, and maintaining muscle mass. Loss of PPARγ abolishes the regulatory effects of USP2 on insulin sensitivity and muscle atrophy. MYOD1 activates USP2 transcription by binding to its promoter region. This study demonstrates the protective role of USP2 in mitigating muscle atrophy by stabilizing PPARγ through deubiquitination, particularly in models of diabetic and DEX-induced muscle atrophy. Targeting the USP2-PPARγ axis may offer promising therapeutic strategies for metabolic disorders and sarcopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PPAR gammaMuscular AtrophyMuscle, SkeletalUbiquitin ThiolesteraseDiabetes Mellitus, Type 2Ubiquitin-Specific ProteasesAnimalsMiceHumansInsulin ResistanceMaleMice, KnockoutDexamethasoneUbiquitinationMice, Inbred C57BLDiabetes Mellitus, Experimental

Substanzen

PPAR gammaUbiquitin ThiolesteraseUsp2 protein, mouseUbiquitin-Specific ProteasesDexamethasoneUSP2 protein, human

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, Guangdong, China.
  • Guangdong Provincial Clinical Research Center for Geriatrics, Shenzhen Clinical Research Center for Geriatrics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hos…
  • The Biobank of National Innovation Center for Advanced Medical Devices, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
  • Shantou University Medical College, Shantou, Guangdong, China.
  • Department of Geriatrics, Peking University Shenzhen Hospital, Shenzhen, China.

ORCID-Profile: Shu Yang, Zhen Liang

Förderung

  • Shenzhen Sustainable Development Science and Technology Special Project, China
  • Key Program
  • National Natural Science Foundation of China

Zitieren

APA

Yang, S., Xiong, L., Liao, T., Li, L., Li, Y., Kang, L., Yang, G., & Liang, Z. (2025). Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ. Diabetes. https://doi.org/10.2337/db24-0375

Vancouver

Yang S, Xiong L, Liao T, Li L, Li Y, Kang L, et al. Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ. Diabetes. 2025. doi:10.2337/db24-0375

BibTeX
@article{Yang2025,
  author = {Yang, Shu and Xiong, Lijiao and Liao, Tingfeng and Li, Lixing and Li, Yanchun and Kang, Lin and Yang, Guangyan and Liang, Zhen},
  title = {Deubiquitinating enzyme USP2 alleviates muscle atrophy by stabilizing PPARγ},
  journal = {Diabetes},
  year = {2025},
  doi = {10.2337/db24-0375}
}
Kostenlos starten →